Brexit leaves industrial firms staring into regulatory void

LONDON (Reuters) - Summit Therapeutics is about to start pivotal tests of a novel antibiotic discovered by UK scientists to treat a sometimes deadly bowel infection, but Britons could be the last patients to get it after Britain leaves the EU.

from Reuters: Top News http://uk.reuters.com/article/uk-britain-eu-regulations-analysis-idUKKBN17S0YY?feedType=RSS&feedName=topNews